Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells

Michael G. Kharas, Vanessa M. Scarfone, Zachary A. Knight et al.|Journal of Clinical Investigation|2008

Cited by 150